REQUEST A DEMO
Total
USD $0.00
Search more companies

Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) is an enterprise located in Iran, with the main office in Tehran. It operates in the Pharmaceutical Preparation Manufacturing industry. Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) was incorporated on April 04, 1998. Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) currently employs 1,196 (2025) people. From the latest financial highlights, Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) reported a net sales revenue increase of 156.95% in Q3C2026. There was a total growth of 36.49% in Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company)’s total assets over the same period. The enterprise’s net profit margin increased by 18.96% in 2026.

Headquarters
18 Km Of Tehran-Karaj Highway - Daropakhsh Street, P.O.Box :11365-4388
Tehran; Tehran; Postal Code: 1397116396

Contact Details: Purchase the Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) report to view the information.

Website: http://www.dppharma.com

Basic Information
Total Employees:
Purchase the Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) report to view the information.
Outstanding Shares:
Purchase the Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) report to view the information.
Financial Auditors:
Purchase the Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) report to view the information.
Incorporation Date:
April 04, 1998
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
82.22%
Purchase this report to view the information.
36.32%
Purchase this report to view the information.
4.65%
Purchase this report to view the information.
2.77%
Purchase this report to view the information.
0.08%
Company Performance
Financial values in the chart are available after Darou Pakhsh Pharmaceutical Manufacturing Company Public Joint Stock (Darou Pakhsh Pharmaceutical Manufacturing Company Public Shareholding Company) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
156.95%
Total Operating Revenue
156.95%
Operating Profit
321.33%
EBITDA
315.03%
Net Profit/Loss for the Period
678.12%
Total Assets
36.49%
Total Equity
33.22%
Operating Profit Margin
18.1%
Net Profit Margin
18.96%
Return on Equity (ROE)
20.26%
Debt / Equity
-8843%
Quick Ratio
394.01%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?